We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
FIGS Q2 Earnings Preview: Is Another Beat in the Cards?
Read MoreHide Full Article
Key Takeaways
FIGS is expected to benefit from healthy customer engagement and continued demand for healthcare apparel.
FIGS expanded its assortment with new fabrics, layering options, launches and inventory planning tools.
FIGS faced possible margin pressure from tariffs, freight expenses and higher marketing costs in Q2.
With FIGS, Inc. (FIGS - Free Report) set to report its second-quarter 2026 earnings results on Aug. 6, after the market closes, investors are asking an important question: Can the healthcare apparel maker maintain its earnings-beat momentum, supported by product innovation, global expansion and strong demand, or will tariffs, freight and elevated marketing costs constrain margin performance?
The Zacks Consensus Estimate for second-quarter revenues stands at $186.1 million, indicating a 21.9% increase from the prior-year reported figure. On the earnings front, the consensus estimate has been stable at 7 cents a share over the past 30 days, implying a year-over-year increase of 75%.
FIGS has a trailing four-quarter earnings surprise of 212.5%, on average. In the last reported quarter, this Santa Monica, CA-based company beat the Zacks Consensus Estimate by 200%.
Image Source: Zacks Investment Research
What the Zacks Model Indicates for FIGS’ Q2 Earnings
As investors prepare for FIGS’ second-quarter results, the question looms regarding an earnings beat or miss. Our proven model does not conclusively predict an earnings beat for FIGS this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, that’s not the case here. You can see the complete list of today’s Zacks #1 Rank stocks here.
FIGS has a Zacks Rank #2 but an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
FIGS’ second-quarter performance is likely to have benefited from sustained momentum in its core business, supported by healthy customer engagement and continued demand for premium healthcare apparel. Management entered the quarter highlighting broad-based strength across categories, geographies and selling occasions while emphasizing that growth was being driven not only by new customer acquisition but also by improving retention and repeat purchasing. The company also pointed to the replenishment-driven nature of healthcare apparel and favorable long-term industry fundamentals, suggesting that demand remained resilient despite a mixed consumer environment. These trends are likely to have supported sales growth.
Product innovation and merchandising initiatives are also likely to have been major drivers during the quarter. FIGS continued to expand its assortment through new fabric platforms, broader layering options and fresh product launches designed to meet a wider range of healthcare professionals’ needs. Seasonal color introductions, the return of popular colors, new maternity offerings and branded collaborations should have encouraged repeat purchases. At the same time, investments in inventory planning tools and supplier partnerships are expected to have improved product availability and enabled the company to respond more quickly to changing customer preferences, supporting stronger full-price demand.
The company’s brand-building initiatives and market expansion efforts are also likely to have contributed to second-quarter performance. Management remained focused on deepening engagement with the healthcare community through purpose-driven marketing campaigns, advocacy initiatives and on-campus events while continuing to strengthen its digital-first ecosystem. International expansion, optimization of existing community hubs and ongoing investments in the TEAMS business are expected to have broadened FIGS’ reach and created incremental demand.
Despite these favorable trends, second-quarter profitability may have faced pressure from external cost headwinds. Higher inbound and outbound freight expenses tied to elevated fuel costs, along with tariff-related impacts, might have weighed on margins during the period. The company also planned a more measured promotional approach during Nurses Week compared with the prior year, which may have tempered some event-driven demand.
FIGS Stock Price Performance
Shares of FIGS have fallen 25.2% over the past three months against the industry’s rise of 3.4%. The stock has underperformed lululemon athletica inc. (LULU - Free Report) and Superior Group of Companies, Inc. (SGC - Free Report) . While shares of Superior Group of Companies have advanced 16.6%, those of lululemon athletica have declined 6.8% over the same period.
Image Source: Zacks Investment Research
Does FIGS Present a Strong Case for Value Investing?
FIGS’ valuation remains elevated relative to the industry. The stock trades at a forward 12-month price-to-sales multiple of 2.38, above the industry average of 1.85 but below its 12-month median of 2.68. FIGS trades at a premium to lululemon athletica (with a forward 12-month P/S ratio of 1.30) and Superior Group of Companies (0.37)
Image Source: Zacks Investment Research
Final Words on FIGS
FIGS appears well positioned heading into its second-quarter earnings, supported by healthy demand trends, continued product innovation and expanding customer engagement across its core and international markets. However, the lack of a positive Earnings ESP suggests that another earnings beat is not strongly indicated despite the company's impressive history of surpassing expectations. While long-term fundamentals remain encouraging and the favorable Zacks Rank reflects confidence in the business, near-term margin pressures from tariffs, freight costs and ongoing growth investments could limit upside. Investors already holding the stock may consider maintaining their positions ahead of the release, while prospective investors may prefer to wait for the earnings report and management's commentary before initiating new positions.
View the Zacks #1 Rank List
Image: Bigstock
FIGS Q2 Earnings Preview: Is Another Beat in the Cards?
Key Takeaways
With FIGS, Inc. (FIGS - Free Report) set to report its second-quarter 2026 earnings results on Aug. 6, after the market closes, investors are asking an important question: Can the healthcare apparel maker maintain its earnings-beat momentum, supported by product innovation, global expansion and strong demand, or will tariffs, freight and elevated marketing costs constrain margin performance?
The Zacks Consensus Estimate for second-quarter revenues stands at $186.1 million, indicating a 21.9% increase from the prior-year reported figure. On the earnings front, the consensus estimate has been stable at 7 cents a share over the past 30 days, implying a year-over-year increase of 75%.
FIGS has a trailing four-quarter earnings surprise of 212.5%, on average. In the last reported quarter, this Santa Monica, CA-based company beat the Zacks Consensus Estimate by 200%.
Image Source: Zacks Investment Research
What the Zacks Model Indicates for FIGS’ Q2 Earnings
As investors prepare for FIGS’ second-quarter results, the question looms regarding an earnings beat or miss. Our proven model does not conclusively predict an earnings beat for FIGS this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. However, that’s not the case here. You can see the complete list of today’s Zacks #1 Rank stocks here.
FIGS has a Zacks Rank #2 but an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
FIGS, Inc. Price, Consensus and EPS Surprise
FIGS, Inc. price-consensus-eps-surprise-chart | FIGS, Inc. Quote
Factors Likely to Have Shaped FIGS’ Q2 Outcome
FIGS’ second-quarter performance is likely to have benefited from sustained momentum in its core business, supported by healthy customer engagement and continued demand for premium healthcare apparel. Management entered the quarter highlighting broad-based strength across categories, geographies and selling occasions while emphasizing that growth was being driven not only by new customer acquisition but also by improving retention and repeat purchasing. The company also pointed to the replenishment-driven nature of healthcare apparel and favorable long-term industry fundamentals, suggesting that demand remained resilient despite a mixed consumer environment. These trends are likely to have supported sales growth.
Product innovation and merchandising initiatives are also likely to have been major drivers during the quarter. FIGS continued to expand its assortment through new fabric platforms, broader layering options and fresh product launches designed to meet a wider range of healthcare professionals’ needs. Seasonal color introductions, the return of popular colors, new maternity offerings and branded collaborations should have encouraged repeat purchases. At the same time, investments in inventory planning tools and supplier partnerships are expected to have improved product availability and enabled the company to respond more quickly to changing customer preferences, supporting stronger full-price demand.
The company’s brand-building initiatives and market expansion efforts are also likely to have contributed to second-quarter performance. Management remained focused on deepening engagement with the healthcare community through purpose-driven marketing campaigns, advocacy initiatives and on-campus events while continuing to strengthen its digital-first ecosystem. International expansion, optimization of existing community hubs and ongoing investments in the TEAMS business are expected to have broadened FIGS’ reach and created incremental demand.
Despite these favorable trends, second-quarter profitability may have faced pressure from external cost headwinds. Higher inbound and outbound freight expenses tied to elevated fuel costs, along with tariff-related impacts, might have weighed on margins during the period. The company also planned a more measured promotional approach during Nurses Week compared with the prior year, which may have tempered some event-driven demand.
FIGS Stock Price Performance
Shares of FIGS have fallen 25.2% over the past three months against the industry’s rise of 3.4%. The stock has underperformed lululemon athletica inc. (LULU - Free Report) and Superior Group of Companies, Inc. (SGC - Free Report) . While shares of Superior Group of Companies have advanced 16.6%, those of lululemon athletica have declined 6.8% over the same period.
Image Source: Zacks Investment Research
Does FIGS Present a Strong Case for Value Investing?
FIGS’ valuation remains elevated relative to the industry. The stock trades at a forward 12-month price-to-sales multiple of 2.38, above the industry average of 1.85 but below its 12-month median of 2.68. FIGS trades at a premium to lululemon athletica (with a forward 12-month P/S ratio of 1.30) and Superior Group of Companies (0.37)
Image Source: Zacks Investment Research
Final Words on FIGS
FIGS appears well positioned heading into its second-quarter earnings, supported by healthy demand trends, continued product innovation and expanding customer engagement across its core and international markets. However, the lack of a positive Earnings ESP suggests that another earnings beat is not strongly indicated despite the company's impressive history of surpassing expectations. While long-term fundamentals remain encouraging and the favorable Zacks Rank reflects confidence in the business, near-term margin pressures from tariffs, freight costs and ongoing growth investments could limit upside. Investors already holding the stock may consider maintaining their positions ahead of the release, while prospective investors may prefer to wait for the earnings report and management's commentary before initiating new positions.